| Literature DB >> 34220971 |
Ahmed Eltarras1, Youssef Jalloul2, Ola Assaad2, Michael Bejjani3, Yara Yammine3, Nina Khatib4, Abdallah Rebeiz2, Mazen El Sayed5, Marwan Refaat2.
Abstract
BACKGROUND: In-hospital cardiac arrest (IHCA) constitutes a significant cause of morbidity and mortality. As data is scarce in the Middle East and Lebanon, we devised this study to shed some light on it to better inform both hospitals and policymakers about the magnitude and quality of IHCA care in Lebanon.Entities:
Year: 2021 PMID: 34220971 PMCID: PMC8220382 DOI: 10.11909/j.issn.1671-5411.2021.06.005
Source DB: PubMed Journal: J Geriatr Cardiol ISSN: 1671-5411 Impact factor: 3.327
Characteristics and outcomes of patients who experienced an IHCA at the American University of Beirut Medical Center between July 1, 2016 and May 2, 2019.
| Variables | IHCA | ROSC | StD | ||
| Data are presented as means ± SD or | |||||
| All | 680 | 380 (55.9%) | 37 (5.6%) | ||
| Sex | |||||
| Male | 466 (68.5%) | 258 (55.4%) | 0.641 | 25 (5.4%) | 0.773 |
| Female | 214 (31.5%) | 122 (57.3%) | 12 (5.6%) | ||
| Age, yrs | 68 ± 17 | 69 ± 18 | 0.36 | 64 ± 20 | 0.13 |
| 18−39 | 66 (9.7%) | 38 (58.5%) | 0.575 | 7 (11.1%) | 0.108 |
| 40−59 | 104 (15.3%) | 50 (48.5%) | 6 (6.1%) | ||
| 60−69 | 122 (17.9%) | 69 (56.6%) | 3 (2.5%) | ||
| 70−79 | 205 (30.1%) | 119 (58.0%) | 14 (7.0%) | ||
| ≥ 80 | 183 (26.9%) | 104 (56.8%) | 7 (3.9%) | ||
| Initial cardiac rhythm | 0.001 | < 0.001 | |||
| Shockable rhythm | 63 (9.3%) | 39 (61.9%) | 12 (19.7%) | ||
| VF | 14 (2.1%) | 9 (64.3%) | 3 (21.4%) | ||
| VT | 31 (4.6%) | 24 (77.4%) | 9 (31.0%) | ||
| VF/VT | 18 (2.6%) | 6 (33.3%) | 0 | ||
| Non-shockable rhythm | 617 (90.7%) | 341 (55.4%) | 25 (4.2%) | ||
| Asystole | 207 (30.4%) | 92 (44.4%) | 2 (1.0%) | ||
| PEA | 331 (48.7%) | 190 (57.6%) | 10 (3.1%) | ||
| PEA/Asystole | 79 (11.6%) | 59 (74.7%) | 13 (17.3%) | ||
| Location | |||||
| Closed units | 598 (87.9%) | 334 (55.9%) | 0.979 | 25 (4.3%) | < 0.001 |
| Non-closed units | 82 (12.1%) | 46 (56.1%) | 12 (15.4%) | ||
| Number of IHCA events | |||||
| 1 | 302 (44.4%) | 99 (32.9%) | < 0.001 | 31 (10.5%) | < 0.001 |
| 2 | 142 (20.9%) | 92 (64.8%) | 2 (1.5%) | ||
| 3 | 84 (12.4%) | 64 (76.2%) | 4 (4.8%) | ||
| 4 | 60 (8.8%) | 47 (78.3%) | 0 | ||
| 5 | 50 (7.4%) | 40 (80.0%) | 0 | ||
| ≥ 6 | 42 (6.2%) | 38 (90.5%) | 0 | ||
| Time from activation to arrival, min | |||||
| < 3 | 621 (93.8%) | 346 (55.7%) | 0.725 | 28 (4.6%) | 0.011 |
| ≥ 3 | 41 (6.2%) | 24 (58.5%) | 6 (15.8%) | ||
| Time of IHCA event | |||||
| Day (7:00−14:59) | 262 (38.8%) | 158 (60.3%) | 0.19 | 19 (7.5%) | 0.132 |
| Evening (15:00−22:59) | 218 (32.3%) | 116 (53.2%) | 9 (4.2%) | ||
| Nightshifts (23:00−6:59) | 195 (28.9%) | 103 (53.1%) | 7 (3.7%) | ||
| Days of week | |||||
| Weekday (Monday–Friday) | 520 (76.5%) | 291 (56.1%) | 0.921 | 34 (6.7%) | 0.026 |
| Weekend (Saturday–Sunday) | 160 (23.5%) | 89 (55.6%) | 3 (1.9%) | ||
| CCI (ten-year survival) | 0.317 | 0.061 | |||
| 0−2 (90%−98%) | 93 (14.1%) | 51 (54.8%) | 11 (12.0%) | ||
| 3 (77%) | 87 (13.1%) | 51 (59.3%) | 4 (4.7%) | ||
| 4−6 (2.2%−53%) | 257 (38.6%) | 135 (52.5%) | 13 (5.2%) | ||
| ≥ 7 (< 0.01%) | 228 (34.3%) | 138 (60.5%) | 9 (4.1%) | ||
Demographics and comorbidities.
| Comorbidity | Number, | Percentage, % |
| Sex | ||
| Male | 446 | 68.5 |
| Female | 214 | 31.5 |
| Age, yrs | ||
| < 50 | 108 | 15.9 |
| 50−59 | 61 | 9.0 |
| 60−69 | 122 | 17.9 |
| 70−79 | 205 | 30.2 |
| ≥ 80 | 183 | 26.9 |
| Myocardial infarction | 111 | 16.6 |
| Congestive heart failure | 213 | 31.9 |
| Peripheral vascular disease | 56 | 8.4 |
| Cerebrovascular accident or transient ischemic attack | 49 | 7.3 |
| Dementia | 11 | 1.7 |
| Chronic obstructive pulmonary disease | 87 | 13.0 |
| Connective tissue disease | 3 | 0.4 |
| Peptic ulcer disease | 8 | 1.2 |
| Liver disease | ||
| Mild | 17 | 2.5 |
| Moderate to severe | 9 | 1.3 |
| Diabetes mellitus II | ||
| Uncomplicated | 143 | 21.4 |
| End-organ damage | 91 | 13.6 |
| Hemiplegia | 2 | 0.3 |
| Moderate to severe chronic kidney disease | 177 | 26.5 |
| Solid tumor | ||
| Localized | 105 | 15.7 |
| Metastatic | 57 | 8.5 |
| Leukemia | 38 | 5.7 |
| Lymphoma | 39 | 5.8 |
| Acquired immunodeficiency syndrome | 1 | 0.1 |
Figure 1Annual IHCA incidence and outcome rates.
Charlson comorbidity index (ten-year survival predictor in patients with multiple comorbidities).
| Variable | ROSC | StD | |||
| OR (95% CI) | OR (95% CI) | ||||
| OR: odds ratios; ROSC: return of spontaneous circulation; StD: survival to discharge. | |||||
| Charlson comorbidity index score | |||||
| 0−2 | − | − | − | − | |
| 3 | 1.20 (0.66−2.17) | 0.55 | 0.355 (0.11−1.16) | 0.087 | |
| 4−6 | 0.91 (0.57−1.47) | 0.70 | 0.391 (0.17−0.91) | 0.029 | |
| ≥ 7 | 1.26 (0.78−2.06) | 0.35 | 0.303 (0.12−0.76) | 0.011 | |
Figure 2Monthly rates of ROSC and StD.